Figure 2.

Anti-glioma Activity of CT-VT-RT as Synergistic Triple Regimen Using TMZ as Chemotherapeutic Agent

The treatment sequence CT-VT-RT is outlined at the indicated concentrations in (A) LN229 and (B) LNZ308 cells. Non-synergistic regimen VT-CT-RT showed poor combinatorial efficacy in (C) LN229 and (D) LNZ308 cells. Similarly, regimen VT-RT-CT exhibited poor combinatorial efficacy in (E) LN229 and (F) LNZ308 cells. Data are expressed as mean ± SEM, n = 9. Calculations of synergy are outlined in Tables S1–S6.